Maged Costantine, MD

Physician, Professor

Maternal Fetal Medicine

Maged Costantine

Contact our office

614-293-8000

Appointments cannot be scheduled directly with this provider.

Conditions and expertise

  • High-Risk Pregnancy
  • Pregnancy
  • Gestational Diabetes
  • Preeclampsia
  • Obstetrics
  • Premature Birth

View all conditions

Locations

  • The Ohio State University Wexner Medical Center

View location details

Academics and research

Department: OB/GYN

View my research

About

Gender
Male
Additional languages
Arabic, French

Biography

As a maternal fetal medicine physician, I’m passionate about helping pregnant moms who have a high-risk condition, whether it’s a maternal disease or fetal complication or anomaly. I treat patients the way I would want to be treated by listening to their concerns, answering questions, being respectful and providing patients with the most up-to-date information in a clear, unbiased manner. It’s a privilege that patients allow me to be involved in their care.

I’m lucky to have trained with amazing Ob/Gyn mentors who taught me how to approach difficult situations in the care of high-risk pregnant mothers. Practicing in an academic medical institution with students, residents and fellows along with my passion to provide the best care for my patients pushes me to be a better doctor. I learn something every day, whether it’s when I’m preparing a lecture, answering a question or taking care of a patient.

As a professor of Obstetrics and Gynecology at The Ohio State University College of Medicine, I’ll often work with students who seek career guidance or someone to discuss research projects with. It reminds me of when I was a student and valued the relationships I had with my mentors, so I try to be a good mentor and role model for my students as well.

I believe incorporating research alongside patient care is essential for advancing the care of patients. I have been working on repurposing cholesterol-lowering drugs (statins) for the prevention or treatment of pregnancy complications, especially preeclampsia. Preeclampsia is a pregnancy complication that affects 3%-8% of pregnant patients and is associated with short- and long-term maternal and neonatal morbidities and mortality.

In my free time, I enjoy spending time with family, playing soccer and traveling.

Highlights

  • Named the Frederick P. Zuspan Professor, Obstetrics and Gynecology
  • Elected a Member for the Society for Maternal-Fetal Medicine Health Policy & Advocacy Committee (HPAC)
  • Director, Division of Maternal Fetal Medicine, The Ohio State University Wexner Medical Center
  • Serving on various National Institutes of Health (NIH) Scientific Review Groups

Conditions and expertise

  • Gestational Diabetes
  • High-Risk Pregnancy
  • Obstetrics
  • Preeclampsia
  • Pregnancy
  • Pregnancy Complications
  • Premature Birth

Locations

Please note: Not all physicians schedule patients at each listed location.

Credentials

Education

Fellowship - Maternal and Fetal Medicine
University of Texas Medical Branch-Galveston, Galveston, TX, United States
7/1/2007 - 6/30/2010
Residency - Obstetrics & Gynecology
The University Hospital-Cincinnati, Cincinnati, OH
7/6/2004 - 6/30/2007
Internship - Obstetrics & Gynecology
WellStar Atlanta Medical Center, Atlanta, GA
7/1/2003 - 6/30/2004
Residency - Obstetrics & Gynecology
American University of Beirut Medical Center, Beirut 1107 2020, Lebanon
8/1/2001 - 6/15/2003
Doctor of Medicine (MD)
American University of Beirut, Beirut, Lebanon
9/1/1997 - 6/30/2001

Certifications

  • American Heart Association National Center
    5/29/2025
  • American Board of Obstetrics & Gynecology-Maternal & Fetal Medicine
    4/10/2013
  • American Board of Obstetrics & Gynecology
    11/7/2008

Academics and research

I am the director of the Division of Maternal Fetal Medicine and the Frederick P. Zuspan MD Chair of Obstetrics and Gynecology. I'm an internationally recognized clinical investigator, having authored more than 140 scholarly articles and book chapters. Recently, my work has focused on the potential role of statins in preventing preeclampsia.

I currently serve as the principal investigator of Ohio State’s site of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. I also serve as the principal investigator or site principal investigator on numerous multicenter federal or industry-sponsored studies of pregnant individuals. I also serve on several Scientific Review Groups for the National Institutes of Health as well as other research organizations in the United States and internationally.

Research interests

  • Hypertensive Disorders of Pregnancy
  • Obstetric Pharmacology
  • Repurposing Statins for Prevention of Obstetric Morbidities
  • Preterm Birth

Academic information

Department:
OB/GYN
Division:
Maternal-Fetal Medicine

Consulting and Related Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 11/3/2025 Dr. Costantine has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.

  • BillionToOne, Inc.
  • Comanche Biopharma
  • Eli Lilly and Company
  • Thieme Publishing

Subscribe. Get just the right amount of health and wellness in your inbox.